The phrase "advantageous safety profile" is correct and usable in written English.
It can be used in contexts related to health, pharmaceuticals, or safety assessments to describe a favorable balance of safety in a product or treatment.
Example: "The new medication has an advantageous safety profile, making it a preferred choice for patients with chronic conditions."
Alternatives: "favorable safety profile" or "beneficial safety profile".
Lowder et al. showed that dexamethasone intravitreal implant was effective in controlling ocular inflammation and had an advantageous safety profile, with less than 10% of treated eyes having an intraocular pressure of 25 mmHg or greater and no significant increased risk of cataract [10].
Bio HA is also demonstrated to provide an advantageous safety profile over AD-HA, as reports demonstrate the association between injection site flare ups and avian-derived proteins.
The different clinical trials leave no doubt on the advantageous safety profile of this ablation technique, with not a single permanent heart block reported till now for atrioventricular nodal reentrant tachycardia (AVNRT).
The data presented indicate an advantageous safety profile and efficacy pattern of PXL150, which warrants further clinical investigations of the potential of this peptide in the treatment of SSTIs.
"Drugs with advantageous safety profiles, in particular drugs that avoid daytime carryover, are not going to make headway with psychiatrists who as a group are prescribing Valium and Xanax during the daytime," says Gary Richardson, a senior research scientist at the Henry Ford Hospital in Detroit.
Although a superiority in the efficacy of the two PA has not been proved yet, cladribine is used more often as first-line agent than pentostatin because of its advantageous administration and safety profile.
Nonviral vectors are advantageous because of their safety profile, low cost, large-scale manufacturing potential, stability, and capacity for a larger nucleic acid payload.
Therefore, development of an alternative fibrinolytic agent having superior efficacy to SK, approaching that of rt-PA, together with a similar or enhanced safety profile and advantageous cost-benefit ratio, would be of substantial importance.
The safety profile of levetiracetam is advantageous, with a very low rate of adverse effects reported (most often somnolence and sedation, and rarely agitation and thrombocytopenia) [ 113].
Regarding outcome, safety profile and administration regimen, the use of cladribine seems to be more advantageous.
"The safety profile is actually quite good.
